Hikma Offers Update On Plans For Advair Rival

Targets Launch In ‘Early 2021’ As Firm Provides Trading Update

2020/1
Hikma’s planned generic Advair launch has been put back to 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business